EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

Dr Moshe Gatt, Hadassah Hebrew University Medical Center, Jerusalem (Israel) summarised for Myeloma Patients Europe (MPE) the main updates on AL amyloidosis presented at the American Society of Hematology (ASH) Annual Meeting held from 7 to 10 December 2019 in Orlando, Florida, USA.

 

 

Ensure you follow @MyelomaEurope and #ASH19 on twitter and on Facebook to see up-to-date developments.







Recent news

» CAR-T cell therapy in myeloma

» Daratumumab subcutaneous, first approved treatment for newly diagnosed AL amyloidosis in Europe

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.